Surinder M. Singh

2.0k citations

28 papers · 1.6k indexed · 2 hit papers · h-index 16

Molecular Biology top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Biotechnology top 2%
Genetics top 10%
Materials Chemistry

Co-authors: Amulya K. Panda Krishna M.G. Mallela Arun K. Upadhyay Anupam Singh Vaibhav Upadhyay Swati Bandi Javier Cabello‐Villegas David N. M. Jones
Topics: Protein purification and stability (13 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Muscle Physiology and Disorders (6 papers)
Cited by: Biotechnology Molecular Biology Radiology, Nuclear Medicine and Imaging
Journals: Proceedings of the National Academy of Sciences PLoS ONE Biochemistry
Partner nations: United States India United Kingdom

In The Last Decade

Surinder M. Singh

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Solubilization and refolding of bacterial inclusion body proteins

2005 574 citations Surinder M. Singh, Amulya K. Panda Journal of Bioscience and Bioengineering profile →
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process

2015 354 citations Anupam Singh, Vaibhav Upadhyay et al. Microbial Cell Factories profile →

Peers

Countries citing papers authored by Surinder M. Singh

Since Specialization

Citations

This map shows the geographic impact of Surinder M. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surinder M. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surinder M. Singh more than expected).

Fields of papers citing papers by Surinder M. Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surinder M. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surinder M. Singh. The network helps show where Surinder M. Singh may publish in the future.

Co-authorship network of co-authors of Surinder M. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Surinder M. Singh. A scholar is included among the top collaborators of Surinder M. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Surinder M. Singh. Surinder M. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals 2023 ·Journal of Pharmaceutical Sciences ·John M. Campbell,Stefano Colombo,(unknown),(unknown),(unknown),Laurent Magnenat,Ann K. Nowinski,(unknown),Surinder M. Singh,(unknown),(unknown),Elaine S. E. Stokes	6
2	Size exclusion chromatography for the characterization and quality control of biologics 2021 ·Journal of Liquid Chromatography & Related Technologies ·Surinder M. Singh,(unknown),Rajesh K. Singh,Gurusamy Balakrishnan,Naresh Chennamsetty,Li Tao,Zheng Jian Li	6
3	A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology 2020 ·Journal of Pharmaceutical Sciences ·(unknown),(unknown),(unknown),Gurusamy Balakrishnan,Surinder M. Singh,Sambit R. Kar,Tapan K. Das	2
4	2D NMR Analysis of the Effect of Asparagine Deamidation Versus Methionine Oxidation on the Structure, Stability, Aggregation, and Function of a Therapeutic Protein 2019 ·Molecular Pharmaceutics ·Swati Bandi,Surinder M. Singh,(unknown),Vaibhav Upadhyay,Krishna M.G. Mallela	15
5	Biophysical analysis of the effect of chemical modification by 4-oxononenal on the structure, stability, and function of binding immunoglobulin protein (BiP) 2017 ·PLoS ONE ·(unknown),Surinder M. Singh,Monika Dzieciątkowska,Krishna M.G. Mallela	4
6	Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy 2017 ·Journal of Pharmaceutical Sciences ·Surinder M. Singh,Swati Bandi,David N. M. Jones,Krishna M.G. Mallela	102
7	Protein recovery from inclusion bodies of Escherichia coli using mild solubilization processbreakdown → 2015 ·Microbial Cell Factories ·Anupam Singh,Vaibhav Upadhyay,Arun K. Upadhyay,Surinder M. Singh,Amulya K. Panda	354
8	Role of Benzyl Alcohol in the Unfolding and Aggregation of Interferon α-2a 2014 ·Journal of Pharmaceutical Sciences ·(unknown),Surinder M. Singh,Javier Cabello‐Villegas,Krishna M.G. Mallela	23
9	Missense Mutation Lys18Asn in Dystrophin that Triggers X-Linked Dilated Cardiomyopathy Decreases Protein Stability, Increases Protein Unfolding, and Perturbs Protein Structure, but Does Not Affect Protein Function 2014 ·PLoS ONE ·Surinder M. Singh,Swati Bandi,(unknown),Geoffrey S. Armstrong,Krishna M.G. Mallela	14
10	High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a 2014 ·Protein Expression and Purification ·(unknown),Tara M. Stauffer,Surinder M. Singh,Thomas Lavoie,Krishna M.G. Mallela	22
11	The Actin Binding Affinity of the Utrophin Tandem Calponin-Homology Domain Is Primarily Determined by Its N-Terminal Domain 2014 ·Biochemistry ·Surinder M. Singh,Swati Bandi,Steve J. Winder,Krishna M.G. Mallela	17
12	Thermodynamic stability, unfolding kinetics, and aggregation of the N‐terminal actin‐binding domains of utrophin and dystrophin 2012 ·Proteins Structure Function and Bioinformatics ·Surinder M. Singh,(unknown),K. Narsimulu,Swati Bandi,Geoffrey S. Armstrong,Steve J. Winder,Krishna M.G. Mallela	16
13	Effect of Antimicrobial Preservatives on Partial Protein Unfolding and Aggregation 2012 ·Journal of Pharmaceutical Sciences ·(unknown),Surinder M. Singh,Javier Cabello‐Villegas,Krishna M.G. Mallela	36
14	The N-Terminal Actin-Binding Tandem Calponin-Homology (CH) Domain of Dystrophin Is in a Closed Conformation in Solution and When Bound to F-actin 2012 ·Biophysical Journal ·Surinder M. Singh,Krishna M.G. Mallela	21
15	Mechanisms of m-cresol-induced Protein Aggregation Studied Using a Model Protein Cytochrome c 2011 ·Journal of Pharmaceutical Sciences ·Surinder M. Singh,(unknown),Krishna M.G. Mallela	33
16	Solubilization of inclusion body proteins using n -propanol and its refolding into bioactive form 2011 ·Protein Expression and Purification ·Surinder M. Singh,Aparna Sharma,Arun K. Upadhyay,Anupam Singh,Lalit C. Garg,Amulya K. Panda	62
17	Role of partial protein unfolding in alcohol‐induced protein aggregation 2010 ·Proteins Structure Function and Bioinformatics ·Surinder M. Singh,Javier Cabello‐Villegas,(unknown),Krishna M.G. Mallela	52
18	High throughput purification of recombinant human growth hormone using radial flow chromatography 2009 ·Protein Expression and Purification ·Surinder M. Singh,Aparna Sharma,Amulya K. Panda	13
19	Solubilization and refolding of bacterial inclusion body proteinsbreakdown → 2005 ·Journal of Bioscience and Bioengineering ·Surinder M. Singh,Amulya K. Panda	574
20	Isolation, Solubilization, Refolding, and Chromatographic Purification of Human Growth Hormone from Inclusion Bodies of <I>Escherichia coli</I> Cells: A Case Study<I> 2005 ·Humana Press eBooks ·Surinder M. Singh,(unknown),Lalit C. Garg,Amulya K. Panda	11

About Surinder M. Singh

Surinder M. Singh is a scholar working on Rehabilitation, Molecular Biology and Cell Biology, having authored 28 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein purification and stability (13 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Muscle Physiology and Disorders (6 papers). The work is most often cited by research in Biotechnology (209 citations), Molecular Biology (1.2k citations) and Radiology, Nuclear Medicine and Imaging (285 citations). Surinder M. Singh has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Amulya K. Panda, Krishna M.G. Mallela, Arun K. Upadhyay, Anupam Singh, Vaibhav Upadhyay, Swati Bandi, Javier Cabello‐Villegas, David N. M. Jones, K. Narsimulu and Aparna Sharma. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact